Bone health is rarely framed as a timing problem, yet the cells that build and break down skeletal tissue operate on strict 24-hour schedules. When those schedules are disrupted — by shift work, jet lag, or genetic variation in clock genes — the balance between bone formation and resorption tilts toward net loss, with implications for osteoporosis risk that have largely been underappreciated in clinical practice.
This narrative review synthesizes evidence across multiple experimental platforms — whole-animal models, isolated tissue preparations, and cell cultures — to map how core circadian clock components govern osteoblast and osteoclast activity. Disruption of central clock genes alters the temporal sequencing of bone remodeling cycles, with global knockouts of components like BMAL1 and CLOCK shifting the ratio of formation to resorption markers measurably toward fragility. The review highlights a key interpretive controversy: global clock-gene knockouts affect every tissue simultaneously, making it difficult to attribute skeletal phenotypes specifically to bone-cell rhythmicity rather than systemic hormonal or metabolic dysregulation. Emerging human-relevant platforms — induced pluripotent stem cell-derived osteoblasts, bone organoids, and microfluidic bone-on-chip systems — are positioned as the next critical step for resolving these ambiguities and identifying chronotherapeutic targets.
The broader significance here extends well beyond basic science. Bisphosphonates and other anti-resorptive agents are already known to show time-of-day pharmacokinetic variation, and the concept of dosing timing to match osteoclast activity peaks is a logical but clinically underdeveloped extension of this biology. The review's framing of integrative multi-model approaches as necessary for reliable conclusions is methodologically sound and reflects a maturation in circadian biology. Limitations are inherent to narrative reviews — no systematic pooling of effect sizes, potential selection bias in studies cited. Still, the synthesis is timely given rising interest in chronopharmacology and the global burden of osteoporotic fractures, making this an incrementally but meaningfully forward-looking contribution.
